DRAEGERWERK AG (DRW8.DE) Stock Fundamental Analysis
Europe - FRA:DRW8 - DE0005550602 - Common Stock
58 EUR
-0.8 (-1.36%)
Overall DRW8 gets a fundamental rating of 5 out of 10. We evaluated DRW8 against 60 industry peers in the Health Care Equipment & Supplies industry. DRW8 has only an average score on both its financial health and profitability. A decent growth rate in combination with a cheap valuation! Better keep an eye on DRW8. These ratings could make DRW8 a good candidate for value investing.
1. Profitability
1.1 Basic Checks
In the past year DRW8 was profitable.
DRW8 had a positive operating cash flow in the past year.
DRW8 had positive earnings in 4 of the past 5 years.
DRW8 had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
DRW8 has a better Return On Assets (3.99%) than 63.33% of its industry peers.
The Return On Equity of DRW8 (8.02%) is better than 61.67% of its industry peers.
DRW8's Return On Invested Capital of 7.67% is fine compared to the rest of the industry. DRW8 outperforms 68.33% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.99% | ||
| ROE | 8.02% | ||
| ROIC | 7.67% |
ROA(3y)1.84%
ROA(5y)3.09%
ROE(3y)3.69%
ROE(5y)7.99%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
DRW8 has a Profit Margin of 3.54%. This is comparable to the rest of the industry: DRW8 outperforms 46.67% of its industry peers.
DRW8's Profit Margin has improved in the last couple of years.
With a Operating Margin value of 6.02%, DRW8 perfoms like the industry average, outperforming 41.67% of the companies in the same industry.
In the last couple of years the Operating Margin of DRW8 has grown nicely.
With a Gross Margin value of 45.35%, DRW8 is not doing good in the industry: 60.00% of the companies in the same industry are doing better.
DRW8's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.02% | ||
| PM (TTM) | 3.54% | ||
| GM | 45.35% |
OM growth 3Y-13.99%
OM growth 5Y11.88%
PM growth 3Y-2.93%
PM growth 5Y32.71%
GM growth 3Y-1.06%
GM growth 5Y0.96%
2. Health
2.1 Basic Checks
DRW8 has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
DRW8 has less shares outstanding than it did 1 year ago.
The number of shares outstanding for DRW8 has been increased compared to 5 years ago.
Compared to 1 year ago, DRW8 has an improved debt to assets ratio.
2.2 Solvency
An Altman-Z score of 2.65 indicates that DRW8 is not a great score, but indicates only limited risk for bankruptcy at the moment.
DRW8 has a Altman-Z score of 2.65. This is comparable to the rest of the industry: DRW8 outperforms 53.33% of its industry peers.
The Debt to FCF ratio of DRW8 is 2.16, which is a good value as it means it would take DRW8, 2.16 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of DRW8 (2.16) is better than 78.33% of its industry peers.
A Debt/Equity ratio of 0.10 indicates that DRW8 is not too dependend on debt financing.
The Debt to Equity ratio of DRW8 (0.10) is better than 73.33% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.1 | ||
| Debt/FCF | 2.16 | ||
| Altman-Z | 2.65 |
ROIC/WACC1.22
WACC6.3%
2.3 Liquidity
DRW8 has a Current Ratio of 1.76. This is a normal value and indicates that DRW8 is financially healthy and should not expect problems in meeting its short term obligations.
DRW8's Current ratio of 1.76 is in line compared to the rest of the industry. DRW8 outperforms 55.00% of its industry peers.
A Quick Ratio of 1.03 indicates that DRW8 should not have too much problems paying its short term obligations.
DRW8 has a Quick ratio of 1.03. This is comparable to the rest of the industry: DRW8 outperforms 43.33% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.76 | ||
| Quick Ratio | 1.03 |
3. Growth
3.1 Past
The Earnings Per Share has been growing slightly by 6.68% over the past year.
DRW8 shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 36.42% yearly.
DRW8 shows a small growth in Revenue. In the last year, the Revenue has grown by 2.14%.
Measured over the past years, DRW8 shows a small growth in Revenue. The Revenue has been growing by 3.92% on average per year.
EPS 1Y (TTM)6.68%
EPS 3Y-2.51%
EPS 5Y36.42%
EPS Q2Q%143.82%
Revenue 1Y (TTM)2.14%
Revenue growth 3Y0.42%
Revenue growth 5Y3.92%
Sales Q2Q%7.58%
3.2 Future
The Earnings Per Share is expected to grow by 6.28% on average over the next years.
Based on estimates for the next years, DRW8 will show a small growth in Revenue. The Revenue will grow by 2.75% on average per year.
EPS Next Y2.66%
EPS Next 2Y10.17%
EPS Next 3Y11.87%
EPS Next 5Y6.28%
Revenue Next Year2.76%
Revenue Next 2Y3.42%
Revenue Next 3Y3.63%
Revenue Next 5Y2.75%
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 8.99, which indicates a very decent valuation of DRW8.
Based on the Price/Earnings ratio, DRW8 is valued cheaply inside the industry as 98.33% of the companies are valued more expensively.
DRW8's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 25.83.
A Price/Forward Earnings ratio of 8.04 indicates a reasonable valuation of DRW8.
95.00% of the companies in the same industry are more expensive than DRW8, based on the Price/Forward Earnings ratio.
DRW8 is valuated cheaply when we compare the Price/Forward Earnings ratio to 32.68, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8.99 | ||
| Fwd PE | 8.04 |
4.2 Price Multiples
DRW8's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. DRW8 is cheaper than 98.33% of the companies in the same industry.
DRW8's Price/Free Cash Flow ratio is rather cheap when compared to the industry. DRW8 is cheaper than 96.67% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 7.95 | ||
| EV/EBITDA | 3.22 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates DRW8 does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)3.39
PEG (5Y)0.25
EPS Next 2Y10.17%
EPS Next 3Y11.87%
5. Dividend
5.1 Amount
DRW8 has a Yearly Dividend Yield of 3.29%.
Compared to an average industry Dividend Yield of 2.13, DRW8 pays a better dividend. On top of this DRW8 pays more dividend than 95.00% of the companies listed in the same industry.
DRW8's Dividend Yield is a higher than the S&P500 average which is at 2.39.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.29% |
5.2 History
The dividend of DRW8 is nicely growing with an annual growth rate of 51.02%!
Dividend Growth(5Y)51.02%
Div Incr Years2
Div Non Decr Years4
5.3 Sustainability
31.13% of the earnings are spent on dividend by DRW8. This is a low number and sustainable payout ratio.
The dividend of DRW8 is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP31.13%
EPS Next 2Y10.17%
EPS Next 3Y11.87%
FRA:DRW8 (11/7/2025, 5:21:35 PM)
58
-0.8 (-1.36%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners10.49%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.09B
Revenue(TTM)3.42B
Net Income(TTM)120.88M
Analysts76
Price Target79.9 (37.76%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.29% |
Yearly Dividend1.77
Dividend Growth(5Y)51.02%
DP31.13%
Div Incr Years2
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)7.96%
PT rev (3m)9.98%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)1.82%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.28%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8.99 | ||
| Fwd PE | 8.04 | ||
| P/S | 0.32 | ||
| P/FCF | 7.95 | ||
| P/OCF | 5.36 | ||
| P/B | 0.72 | ||
| P/tB | 0.93 | ||
| EV/EBITDA | 3.22 |
EPS(TTM)6.45
EY11.12%
EPS(NY)7.22
Fwd EY12.44%
FCF(TTM)7.29
FCFY12.58%
OCF(TTM)10.82
OCFY18.65%
SpS182.27
BVpS80.37
TBVpS62.21
PEG (NY)3.39
PEG (5Y)0.25
Graham Number108
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.99% | ||
| ROE | 8.02% | ||
| ROCE | 10.2% | ||
| ROIC | 7.67% | ||
| ROICexc | 8.64% | ||
| ROICexgc | 10.67% | ||
| OM | 6.02% | ||
| PM (TTM) | 3.54% | ||
| GM | 45.35% | ||
| FCFM | 4% |
ROA(3y)1.84%
ROA(5y)3.09%
ROE(3y)3.69%
ROE(5y)7.99%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y-18.01%
ROICexgc growth 5Y12.44%
ROICexc growth 3Y-16.98%
ROICexc growth 5Y13.06%
OM growth 3Y-13.99%
OM growth 5Y11.88%
PM growth 3Y-2.93%
PM growth 5Y32.71%
GM growth 3Y-1.06%
GM growth 5Y0.96%
F-Score7
Asset Turnover1.13
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.1 | ||
| Debt/FCF | 2.16 | ||
| Debt/EBITDA | 0.44 | ||
| Cap/Depr | 44.92% | ||
| Cap/Sales | 1.93% | ||
| Interest Coverage | 11.48 | ||
| Cash Conversion | 57.51% | ||
| Profit Quality | 113.22% | ||
| Current Ratio | 1.76 | ||
| Quick Ratio | 1.03 | ||
| Altman-Z | 2.65 |
F-Score7
WACC6.3%
ROIC/WACC1.22
Cap/Depr(3y)46.64%
Cap/Depr(5y)59.31%
Cap/Sales(3y)2.11%
Cap/Sales(5y)2.52%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)6.68%
EPS 3Y-2.51%
EPS 5Y36.42%
EPS Q2Q%143.82%
EPS Next Y2.66%
EPS Next 2Y10.17%
EPS Next 3Y11.87%
EPS Next 5Y6.28%
Revenue 1Y (TTM)2.14%
Revenue growth 3Y0.42%
Revenue growth 5Y3.92%
Sales Q2Q%7.58%
Revenue Next Year2.76%
Revenue Next 2Y3.42%
Revenue Next 3Y3.63%
Revenue Next 5Y2.75%
EBIT growth 1Y12.74%
EBIT growth 3Y-13.63%
EBIT growth 5Y16.27%
EBIT Next Year81.51%
EBIT Next 3Y29.6%
EBIT Next 5Y12.23%
FCF growth 1Y20.52%
FCF growth 3Y-27.65%
FCF growth 5Y0.28%
OCF growth 1Y11.8%
OCF growth 3Y-24.25%
OCF growth 5Y0.35%
DRAEGERWERK AG / DRW8.DE FAQ
Can you provide the ChartMill fundamental rating for DRAEGERWERK AG?
ChartMill assigns a fundamental rating of 5 / 10 to DRW8.DE.
What is the valuation status for DRW8 stock?
ChartMill assigns a valuation rating of 7 / 10 to DRAEGERWERK AG (DRW8.DE). This can be considered as Undervalued.
What is the profitability of DRW8 stock?
DRAEGERWERK AG (DRW8.DE) has a profitability rating of 5 / 10.
What are the PE and PB ratios of DRAEGERWERK AG (DRW8.DE) stock?
The Price/Earnings (PE) ratio for DRAEGERWERK AG (DRW8.DE) is 8.99 and the Price/Book (PB) ratio is 0.72.
Can you provide the expected EPS growth for DRW8 stock?
The Earnings per Share (EPS) of DRAEGERWERK AG (DRW8.DE) is expected to grow by 2.66% in the next year.